TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$35.02 USD
-0.48 (-1.35%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $35.04 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
TG Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TGTX 35.02 -0.48(-1.35%)
Will TGTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TGTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TGTX
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 Release
TGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Options Traders Betting on a Big Move in TG Therapeutics Stock?
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
Other News for TGTX
Here are the major earnings before the open Monday
TG Therapeutics (TGTX) Prepares for Q2 Earnings Announcement with High Expectations
TG Therapeutics Q2 2025 Earnings Preview
What's Next: TG Therapeutics's Earnings Preview
The Play On TG Therapeutics